Bridging the Gap Between Basic and Clinical Electrophysiology: What Can Be Learned From Monophasic Action Potential Recordings?

Journal of Cardiovascular Electrophysiology

Volumn 5, Issue 8, 1994, Pages 699-710

  FRANZ, MICHAEL R ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

afterdepolarizations; antiarrhythmic drugs; catheter ablation; mechano electrical feedback; Monophasic action potentials; myocardial ischemia; use dependency; ventricular fibrillation

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; ISOPRENALINE; PROCAINAMIDE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CLINICAL PRACTICE; DEFIBRILLATION; DOSE RESPONSE; DRUG EFFECT; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMAL; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; HEART; HEMODYNAMICS; HUMAN; MYOCARDIAL ISCHEMIA; REFRACTORY PERIOD, NEUROLOGIC;

EID: 0028146720     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1994.tb01192.x     Document Type: Review

References (54)

1. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial
2. Reassessment of benefit‐risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial
3. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The Sicilian gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
4. Long‐term recording of monophasic action potentials from human endocardium
5. In vitro validation of a new cardiac catheter technique for recording monophasic action potentials
6. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo
7. Right ventricular monophasic action potentials during regular rhythm. A heart catheterization study in man
8. Method and theory of monophasic action potential recording
9. Relation of monophasic action potential recorded with contact electrode to underlying transmembrane action potential properties in isolated cardiac tissues: A systematic microelectrode validation study
10. Cesium chloride‐induced long QT syndrome: Demonstration of afterdepolarizations and triggered activity in vivo
11. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence
12. Antiarrhythmic agents: Modulated receptor applications
13. Cellular electrophysiological effect of D‐ and DL‐sotalol in guinea‐pig sinoairial node, atrium and ventricle and human atrium: Differential tissue sensitivity
14. Frequency dependent effects of d‐oialol and amiodarone on the action potential duration of the human right ventricle
15. Electrophysiologic and antiarrhythmic effects of D‐sotulol
16. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris
17. Relation between repolarizalion and refractoriness in the human ventricle: Cycle length dependence and effect of procainamide
18. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease
19. Frequency‐dependent electrophysiologic effects of amiodarone in humans
20. Frequency‐dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ
21. Kinetics of onset of rate‐dependent effects of Class 1 antiarrhylhmic drugs are important in determining their effects on refractoriness in guinea‐pig ventricle, and provide a theoretical basis for their subclassification
22. Frequency‐dependent effect ot quinidine, mexiletine, and their combination on post re polarization refractoriness in vivo
23. Frequency‐dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo
24. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
25. Electrocardiographic and electrophysiologic studies in patients with torsades de pointes‐Role of monophasic action potentials
26. Monophasic action potentials in the diagnosis of triggered arrhythmias
27. Distinctive features of ventricular fibrillation and ventricular tachycardia detected by monophasic action potential recording in human subjects
28. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart
29. (The V‐HeFT II VA Cooperative Studies Group): Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure
30. Clinical significance and management of arrhythmias in the heart failure patient
31. Excitation‐contraction coupling in heart failure
32. Ventricular arrhythmias in congestive heart failure
33. Feedback interaction of mechanical and electrical events in the isolated ventricular myocardium (cat papillary muscle]
34. Mechanically dependent changes in action potentials recorded from the intact frog ventricle
35. Stretch‐activated ion channels and membrane mechanics
36. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch‐activated arrhythmias [published erratum appears in Circulation
37. Stretch‐induced depolarizations as a trigger of arrhythmias in isolated canine left ventricles
38. Mechanoelectrical feedback: Independent role of preload and contractility in modulation of canine ventricular excitability [published erratum appears in J Clin Invest
39. Mechanically induced action potential changes and arrhythrnia in isolated and in situ canine hearts
40. Amplitude and polarity of stretch‐induced systolic and diastolic voltage changes depend on the timing of stretch: A means to characterize stretch‐activated channels in the intact heart
41. Stretch activated ion channels in ventricular myocytes
42. Interaction between ventricular loading and repolarisation: Relevance to arrhythmogenesis
43. Mechanism of ventricular arrhythmias caused by increased dispersion of re.polarization
44. Contraction‐excitation feedback in the atria: A cause of changes in refractoriness
45. Changes in myocardial repolarization in patients undergoing balloon valvtuloplasty for congenital pulmonary stenosis: Evidence for contraction‐excitation feedback in humans
46. Effects of posture, Valsalva maneuver and respiration on atrial flutter rate: An effect mediated through cardiac volume
47. Monophasic action potential recordings during acute changes in ventricular loading induced by the Valsalva manoeuvre
48. Precordial and epicardial surface potentials during myocardial ischemia in the pig. A theoretical and experimental analysis of the TQ and ST segments
49. Relation between monophasic action potential duration, ST segment elevation, and regional myocardial blood flow after coronary occlusion in the pig
50. Localization of regional myocardial ischemia by recording of monophasic action potentials
51. In vivo electrophysiological detection of myocardial ischemia through monophasic action potential recording
52. Use of monophasic action potential recordings during routine coronary‐artery bypass surgery as an index of localised myocardial ischaemia
53. TU alternans, long QTU, and torsade de pointes: Clinical and experimental observations